K-numberK250747
Device nameGlobe® Pulsed Field System
ApplicantKardium, Inc.
Product codeDQK
Device classClass II
Decision dateJun 25, 2025
DecisionSubstantially Equivalent
Regulation870.1425
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Globe Pulsed Field System is a cardiac mapping and stimulation device used for catheter-based electrophysiological mapping and pacing of heart tissue. It consists of a controller unit, workstation with software, and surface positioning electrodes that work together to acquire cardiac signals, create 3D anatomical maps, and deliver diagnostic stimulation pulses.

Technological characteristics

The Globe PF System uses impedance-based catheter tracking (unlike the predicate's dual impedance/magnetic tracking), includes a Globe Controller and Workstation rather than a catheter interface unit, delivers internal-only stimulation at 10mA maximum, and adds contact mapping features (FLOW and CONTACT maps) based on thermal energy delivery principles similar to the Swan-Ganz reference device.

Test standards cited

Not stated in this summary. The document references 'applicable principles and recommendations of relevant FDA-recognized consensus standards and guidance documents' but does not name specific standards such as ISO, IEC, or ASTM numbers.

Substantial equivalence argument

The Globe PF System is substantially equivalent because it shares identical intended use and indications (catheter-based cardiac mapping and stimulation) with the predicate Affera device, employs the same fundamental impedance-based tracking technology, and includes equivalent core components (controller/workstation, software for electroanatomical mapping, ECG/electrogram acquisition, and stimulation capability). The differences—removal of magnetic tracking, internal-only stimulation, and addition of contact maps using thermal sensing principles from the Swan-Ganz reference device—do not raise new safety or effectiveness questions since the contact mapping relies on established thermal energy principles and the removals represent simplifications rather than novel technology.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →